ArticlePediatric nephrology (Berlin, Germany)2017

Efficacy and safety of rituximab in comparison with common induction therapies in pediatric active lupus nephritis.

Biswanath Basu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.